Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Novel GLA Mutation Promotes Intron Inclusion Leading to Fabry Disease

Full text
Varela, Patricia [1] ; Caldas, Myrtes Martins [2] ; Pesquero, Joao Bosco [1]
Total Authors: 3
[1] Univ Fed Sao Paulo, Ctr Res & Mol Diagnost Genet Dis, Dept Biophys, Sao Paulo - Brazil
[2] Dept Nephrol URONEFRO Hemodialise & Especialidade, Belem, Para - Brazil
Total Affiliations: 2
Document type: Journal article
Source: FRONTIERS IN GENETICS; v. 10, SEP 27 2019.
Web of Science Citations: 0

Fabry disease (FD) is a rare and underdiagnosed X-linked disorder resulting from the deficient activity of the lysosomal hydrolase alpha-galactosidase A, which leads to storage of complex glycosphingolipids inside of lysosomes in critical organs and tissues, impairing their functions and consequently resulting in a progressive multisystem disease. FD is caused by mutations in the GLA gene, and only 4.6% of described mutations are located in the splice site regions. RNA splicing is an essential step to the formation of functional proteins, and mutations in splice site regions can cause formation of aberrant transcripts leading to disease. Here we report a novel GLA insertion at position c.801+3 in intron 5 (c.801+2\_801+3insT) in a Brazilian family with suspicion of FD. The index case, a 46-year-old male, presented undetectable alpha-galactosidase A activity. Analysis of blood cDNA found two aberrant GLA transcripts. In the first transcript, a novel donor splice site was created promoting formation of an intron inclusion with 37 bp. The splice site was not recognized in the second transcript and the intron 5 was not excised. The wild-type transcript was not formed and both aberrant transcripts lead to a premature stop codon. Despite not being in the canonical site, this new mutation disrupts existing 5' splice site and produces two aberrant transcripts leading to FD. (AU)

FAPESP's process: 14/27198-8 - Establishment of a center of genetic and molecular research for clinical challenges
Grantee:João Bosco Pesquero
Support type: Research Projects - Thematic Grants